Record EBITDA margin comes with a supply chain tail risk

On the surface, Yasho Industries delivered what the market wanted to see: ₹308 crore revenue (+55% YoY), ₹36.1 crore net profit (+889% YoY), and a record EBITDA margin of 24.2%—a jump of 720 basis points from the prior year's 17%. Rating upgrades followed (CRISIL/ICRA moved to A-). But the earnings call exposed the real tension: this 24.2% margin is at the company's 8-year high, resting on three temporary levers that analysts pressed management hard to defend.

Management attributed the +720 bps margin jump to three factors. First, capacity leverage: utilization climbed from 50% to 65% at the Pakhajan facility, driving fixed-cost absorption. Second, product mix: new-chemistry products launched in the prior 24 months now contribute ~30% of revenue and carry 10–12% higher margins than legacy lines. Third, long-term customer contracts: the company shifted 50%+ of revenue mix into quarterly/6-month/yearly formula-based pricing (up from 30–40% spot), which locks in pass-through economics and reduces spot-price volatility. The arithmetic is clean—volume +42%, price/mix contributing ~13% of the 55% revenue growth—but the sustainability question is whether all three levers remain in place simultaneously.

Yasho raised two critical guidances. FY28 revenue target lifted to >₹1,600 crore (from ₹1,500 Cr prior guidance). CAPEX doubled to ₹250 crore (from ₹125 Cr plan), split into two phases: ₹100 Cr in Phase-1 (commissioning Q1 FY28) and ₹150 Cr in Phase-2 (Q4 FY28) for production buildings at Pakhajan. Management projects these assets will generate 2.5x asset turns—implying ~₹500–600 Cr in incremental revenue potential. Critically, 60–65% of the new capacity is already pre-booked by marquee customers via long-term agreements (exact customer names under NDA). The long-term contract mix itself grew from 30–40% spot-pricing to 50%+, a structural shift toward price stability. These moves are bullish on the surface—a clear growth plan backed by customer commitments—but also signal management's intent to lock in customers before execution risk on the CAPEX ramp plays out.

The stock reacted strongly to the result: day-1 pop +0.68%, accelerating to +7.74% by day-3 and +8.2% by day-5 post-announcement. That 8.2% move has held, confirming the market's fundamental read on the earnings beat and guidance raise. However, RSI at 78 signals overbought territory—a typical warn flag for caution on further upside without a pullback. The stock now trades ₹4,175, sitting 269% above its 52-week low (₹1,130) but 7% below its all-time high (₹4,489.50). It trades comfortably above all major moving averages (SMA20 ₹3,393, SMA50 ₹2,990, SMA200 ₹1,878), confirming an established uptrend but also suggesting limited margin of safety at current levels.

Institutional positioning is modest. FII ownership held flat (5.74% in Q1 FY27 vs. 5.71% in Q4), suggesting institutions are neither adding heavily nor retreating post-result. DII inflows were marginal (+0.24pp to 2.21%). Promoter stake remained stable at 67.94%. The absence of aggressive institutional accumulation on the back of this beat is notable—it suggests the market is pricing in the margin and CAPEX risks already, or waiting for Q2 proof-of-concept on margin sustenance before committing fresh capital.